Physician profile
Jacqueline Louise Trussell
NPI 1982040291
$15,070.98
in general payments reported to CMS, 2019-2025
14 companies · $14K in 2025
The $14K reported for 2025 was more than what 99% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $121 · 2024: $934 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Travel and Lodging: $2,313 · Food and Beverage: $2,134 · Education: $83.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,540.00 |
| Travel and Lodging | $2,313.16 |
| Food and Beverage | $2,133.83 |
| Education | $83.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $13,876.49 | 2024-2025 | Carvykti, Rybrevant, Tecvayli |
| Servier Pharmaceuticals LLC | $224.32 | 2024 | |
| Celgene Corporation | $141.30 | 2023-2025 | Reblozyl, Breyanzi |
| Janssen Scientific Affairs, LLC | $135.56 | 2025 | Carvykti, Darzalex, Talvey |
| Genzyme Corporation | $125.00 | 2025 | |
| Amgen INC. | $121.88 | 2025 | Imdelltra (Amg757) |
| E.R. Squibb & Sons, L.L.C. | $121.88 | 2024 | |
| Astrazeneca Pharmaceuticals Lp | $80.78 | 2024 | Calquence |
| Genmab U.S., INC. | $65.79 | 2024 | Epkinly |
| Legend Biotech USA INC. | $55.25 | 2024-2025 | Carvykti |
| Kite Pharma, INC. | $42.57 | 2025 | Yescarta |
| Adaptive Biotechnologies Corporation | $35.84 | 2025 | Clonoseq |
| Adaptimmune LLC | $24.09 | 2025 | |
| Abbvie INC. | $20.23 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Trussell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.